Table 3.
Current development status of NFκB pathway inhibitors. (Investigational Drugs DataBase, Nov 15 2005 [106], advanced search by activity field on Nuclear factor kappa B inhibitor)
| Development status | No. of drugs |
| Discovery Research | 22 |
| Clinical (unspecified) | 1 |
| Phase I clinical trials | 4 |
| Phase II clinical trials | 4 |
| Phase III clinical trials | 0 |
| Pre-registered | 0 |
| Registered | 0 |
| Launched | 1 bortezomib |
| Research tools | 1 |
| Suspended | 0 |
| Withdrawn | 0 |
| No development reported | 4 |
| Discontinued | 4 |